Biomarin Pharmaceutical Inc (BMRN)
81.00
-0.72
(-0.88%)
USD |
NASDAQ |
May 10, 16:00
81.00
0.00 (0.00%)
After-Hours: 19:47
Biomarin Pharmaceutical Market Cap: 15.38B for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 09, 2024 | 15.52B |
| May 08, 2024 | 15.54B |
| May 07, 2024 | 15.68B |
| May 06, 2024 | 15.59B |
| May 03, 2024 | 15.65B |
| May 02, 2024 | 15.91B |
| May 01, 2024 | 15.82B |
| April 30, 2024 | 15.33B |
| April 29, 2024 | 15.59B |
| April 26, 2024 | 15.36B |
| April 25, 2024 | 15.60B |
| April 24, 2024 | 17.32B |
| April 23, 2024 | 17.48B |
| April 22, 2024 | 16.99B |
| April 19, 2024 | 16.82B |
| April 18, 2024 | 17.09B |
| April 17, 2024 | 17.17B |
| April 16, 2024 | 17.24B |
| April 15, 2024 | 17.37B |
| April 12, 2024 | 17.50B |
| April 11, 2024 | 17.36B |
| April 10, 2024 | 17.12B |
| April 09, 2024 | 16.89B |
| April 08, 2024 | 16.56B |
| April 05, 2024 | 16.50B |
| Date | Value |
|---|---|
| April 04, 2024 | 16.49B |
| April 03, 2024 | 16.47B |
| April 02, 2024 | 16.47B |
| April 01, 2024 | 16.53B |
| March 28, 2024 | 16.57B |
| March 27, 2024 | 16.82B |
| March 26, 2024 | 16.65B |
| March 25, 2024 | 16.42B |
| March 22, 2024 | 16.07B |
| March 21, 2024 | 15.87B |
| March 20, 2024 | 16.00B |
| March 19, 2024 | 16.09B |
| March 18, 2024 | 15.82B |
| March 15, 2024 | 15.83B |
| March 14, 2024 | 15.92B |
| March 13, 2024 | 15.99B |
| March 12, 2024 | 16.07B |
| March 11, 2024 | 16.23B |
| March 08, 2024 | 16.22B |
| March 07, 2024 | 16.21B |
| March 06, 2024 | 16.37B |
| March 05, 2024 | 16.23B |
| March 04, 2024 | 16.55B |
| March 01, 2024 | 16.44B |
| February 29, 2024 | 16.28B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
11.54B
Minimum
Oct 02 2019
23.74B
Maximum
Jul 20 2020
15.97B
Average
15.67B
Median
Market Cap Benchmarks
| Pfizer Inc | 158.75B |
| Eli Lilly and Co | 722.44B |
| Merck & Co Inc | 329.34B |
| Bristol-Myers Squibb Co | 91.08B |
| Moderna Inc | 44.96B |
Market Cap Related Metrics
| PE Ratio | 75.70 |
| PS Ratio | 6.341 |
| PEG Ratio | 0.4146 |
| Price to Book Value | 3.031 |
| Price to Free Cash Flow | 96.02 |
| Price | 81.00 |
| Earnings Yield | 1.32% |
| PEGY Ratio | 0.4146 |
| Operating PE Ratio | 88.45 |
| Normalized PE Ratio | 78.81 |